Vets CURED PTSD with Magic Mushrooms? Shocking Study Results!

Did you know that 9 out of 12 military veterans, suffering from severe, treatment-resistant PTSD, achieved remission after participating in a small U.S. pilot study involving the psychedelic drug psilocybin? This groundbreaking research offers a glimmer of hope for a population for whom conventional treatments have failed, despite psilocybin being classified as a controlled substance akin to heroin in the United States. Following these striking preliminary results, President Donald Trump has even signed an executive order, urging health regulators to expedite reviews and increase federal funding for psychedelic treatment research. The 11-week trial involved psychotherapy sessions coupled with two doses of synthetic psilocybin, yielding minimal side effects like mild headaches. Researchers from The Ohio State University, who led this first formal test of psilocybin in veterans with PTSD, are now actively seeking funding for larger, randomized clinical trials to further validate these astonishing findings. While still in its early stages, this treatment suggests a revolutionary path forward for mental health, building on similar limited authorizations already seen in Australia and Switzerland. To stay informed on these groundbreaking medical advancements and more, be sure to subscribe to our channel!

Tags/Hashtags: #psilocybin #PTSD #veterans #psychedelic #mentalhealth #clinicaltrial #OhioStateUniversity #Trump #treatmentresistant #remission #AlanDavis #StaceyArmstrong #DonaldTrump #TheOhioStateUniversityCollegeofSocialWork #CommunicationsMedicine #UnitedStates #Australia #Switzerland #psilocybinstudy #executiveorder